Advisory Council on the Misuse of Drugs (2013) ACMD further advice on foil. London: Advisory Council on the Misuse of Drugs
Advisory Council on the Misuse of Drugs (2010) Consideration of the anabolic steroids. London: Advisory Council on the Misuse of Drugs.
Advisory Council on the Misuse of Drugs (2003) Hidden harm – responding to the needs of children of problem drug users. London: Advisory Council on the Misuse of Drugs.
Cusick L, Martin A, May T (2003) Vulnerability and involvement and in drug use and sex work. London: Home Office.
Davies C, English L, Lodwick A et al. (2010) United Kingdom drug situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2010. London: UK Focal Point on Drugs, Department of Health.
Davies C, English L, Stewart C et al. (2012) United Kingdom drug situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2012. Liverpool: UK Focal Point on Drugs, Liverpool John Moores University
Evans-Brown M, Dawson RT, Chandler M et al. (2009) Use of melanotan I and II in the general population. British Medical Journal 338: b566.
Evans-Brown M, McVeigh J, Perkins C et al. (2012) Human enhancement drugs: the emerging challenges to public health. Liverpool: North West Public Health Observatory, Centre for Public Health, Liverpool John Moores University.
Hay G, Rael dos Santos A, Millar T (2011) National and regional estimates of the prevalence of opiate and/or crack cocaine use, 2010–11: a summary of key findings. London: National Treatment Agency for Substance Misuse.
Health Protection Agency (2012) United Kingdom. New HIV diagnoses to end of December 2012. [Accessed 10 July 2013]
Health Protection Agency (2010) Shooting up: infections among injecting drug users in the United Kingdom 2009. London: Health Protection Agency.
Health Protection Agency, Health Protection Scotland, National Public Health Service for Wales et al. (2007) Shooting up: infections among injecting drug users in the United Kingdom, 2006. London: Health Protection Agency
Hickman M, Higgins V, Hope V et al. (2004) Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators. Journal of Epidemiology and Community Health 58: 766–71
HM Government (2003) The Misuse of Drugs Act: 2003 (amendment) (no.2) regulations 2003
Home Office (2012) Drug misuse declared: findings from the 2011/12 British Crime Survey for England and Wales. London: Home Office.
Home Office (2003) Home Office circular 035/2003 Supply of drug injecting paraphernalia. London: Home Office
Hope VD, McVeigh J, Marongiu A et al. (2013) Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. British Medical Journal Open 3: e003207
Lenehan P, Bellis MA, McVeigh J (1996) A study of anabolic steroid use in the North West of England. Journal of Performance Enhancing Drugs 1: 57–70
McVeigh J, Beynon C, Bellis MA (2003) New challenges for agency based syringe exchange schemes: analysis of 11 years of data (1991–2001) in Merseyside and Cheshire, United Kingdom. International Journal of Drug Policy 14: 399–405
McVeigh J, Chandler M, Beynon C et al. (2007) The injectors that harm reduction forgot. Poster presented at the 18th International Conference on the Reduction of Drug Related Harm, 13–17 May 2007, Warsaw, Poland.
Melrose M (2004) Fractured transitions: disadvantaged young people, drug taking and risk. Probation Journal 51: 327–41
Public Health England, Centre for Infectious Disease Surveillance & Control and Microbiology Services (2013a). Unlinked anonymous monitoring survey of people who inject drugs in contact with specialist services: data tables. London: Public Health England.
Public Health England (2013b) Hepatitis C in the UK 2013 report. London: Public Health England.
Ward J, Henderson Z, Pearson G (2003) One problem among many: drug use among care leavers in transition to independent living Home Office Research Study. London: Home Office
World Health Organization (2007) Guide to starting and managing needle and syringe programmes. Geneva: World Health Organization